Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1-2
pubmed:dateCreated
2008-4-29
pubmed:abstractText
Topical photodynamic therapy (PDT) with 5-aminolevulinic acid (ALA) is an alternative therapy for many non-melanoma skin cancers. The major limitation of this therapy, however, is the low permeability of ALA through the stratum corneum (SC) of the skin. The objective of the present work was to characterize ethosomes containing ALA and to enhance the skin production of protoporphyrin IX (PpIX), compared to traditional liposomes. Results showed that the average particle sizes of the ethosomes were less than those of liposomes. Moreover, the entrapment efficiency of ALA in the ethosome formulations was 8-66% depending on the surfactant added. The particle size of the ethosomes was still approximately <200 nm after 32 days of storage. An in vivo animal study observed the presence of PpIX in the skin by confocal laser scanning microscopy (CLSM). The results indicated that the penetration ability of ethosomes was greater than that of liposomes. The enhancements of all the formulations were ranging from 11- to 15-fold in contrast to that of control (ALA in an aqueous solution) in terms of PpIX intensity. In addition, colorimetry detected no erythema in the irradiated skin. The results demonstrated that the enhancement ratio of ethosome formulations did not significantly differ between the non-irradiated and irradiated groups except for PE/CH/SS, which may have been due to a photobleaching effect of the PDT-irradiation process.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0378-5173
pubmed:author
pubmed:issnType
Print
pubmed:day
22
pubmed:volume
356
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
144-52
pubmed:meshHeading
pubmed-meshheading:18325699-Aminolevulinic Acid, pubmed-meshheading:18325699-Animals, pubmed-meshheading:18325699-Chemistry, Pharmaceutical, pubmed-meshheading:18325699-Drug Stability, pubmed-meshheading:18325699-Drug Storage, pubmed-meshheading:18325699-Ethanol, pubmed-meshheading:18325699-Female, pubmed-meshheading:18325699-Liposomes, pubmed-meshheading:18325699-Mice, pubmed-meshheading:18325699-Mice, Inbred ICR, pubmed-meshheading:18325699-Mice, Nude, pubmed-meshheading:18325699-Particle Size, pubmed-meshheading:18325699-Permeability, pubmed-meshheading:18325699-Photochemotherapy, pubmed-meshheading:18325699-Photosensitizing Agents, pubmed-meshheading:18325699-Protoporphyrins, pubmed-meshheading:18325699-Skin Absorption, pubmed-meshheading:18325699-Skin Neoplasms, pubmed-meshheading:18325699-Surface-Active Agents
pubmed:year
2008
pubmed:articleTitle
Comparison of 5-aminolevulinic acid-encapsulated liposome versus ethosome for skin delivery for photodynamic therapy.
pubmed:affiliation
Graduate Institute of Pharmaceutical Sciences, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't